SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
about
The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis.Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumorsInhibition of medulloblastoma cell invasion by SlitInactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significancesAngiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progressionUSP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastomaSlit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesisSlit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells.Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinomaEpigenetics of renal cell carcinoma: the path towards new diagnostics and therapeuticsThe epigenetics of renal cell tumors: from biology to biomarkers.Immunohistochemical staining of slit2 in primary and metastatic prostatic adenocarcinoma.Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.Maximal Expression of the Evolutionarily Conserved Slit2 Gene Promoter Requires Sp1.The epigenetic landscape of renal cancer.Reduced expression of Slit2 in renal cell carcinoma.Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3β signaling pathway.The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.
P2860
Q24314397-7A88827E-A000-413D-9381-918BBBB54B22Q24678285-C3C8A40D-8339-4B0E-B140-E77C7955A503Q24680387-BDF15E90-553C-412B-ADB4-967D8DE802ACQ34311871-AF5E0A26-CA40-4F8C-A9BD-3C5CD7C5C23FQ34547793-F74FDCD5-1D37-4203-BA45-4EC246B5E42EQ34695790-13D3E412-A2EC-449B-862E-BC08A656DEB6Q35070268-3DE35270-F8D9-41CC-8BBF-AFC66BAAD272Q35126668-0C0A908A-71D8-4CCF-B56F-A631F46D47C5Q35469063-37430E2F-8F4E-4815-93C5-22E51C77AB79Q36897655-CCBCB3EF-6676-4F2C-BB90-0E33D6E45A70Q36982125-6FF40DB4-17EF-4EAB-B357-34E8653A3107Q37785109-11BE1A3A-33BC-42F3-AD5F-E59038051409Q38016153-919A6620-BBA1-4F74-BCE2-E4EBCFE75A24Q38263430-EE4F80A5-5296-4726-AE31-DF60A1DBE304Q38799612-BB8DB9D8-F444-4AB6-869F-EC5A124EFB57Q38828786-8E32D08B-47B8-49F1-9405-EE16B8D2033AQ39021700-28C909FE-DDC7-4EC5-9A83-499F11F3E65EQ39052352-5EF79529-D519-4BAB-B88E-A72E0BD2B7BDQ39086320-24327636-C95A-416D-A443-E958AAED97B2Q39211407-06D4F48D-ADDC-4F25-952C-0324F26739F5Q42415938-3A2A441C-E0B5-4CD0-BF01-2C6331880FF2Q54977184-15EA7C80-71A5-4263-91BF-1B793076666E
P2860
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@ast
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@en
type
label
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@ast
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@en
prefLabel
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@ast
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@en
P2093
P2860
P50
P356
P1476
SLIT2 promoter methylation ana ...... umour and renal cell carcinoma
@en
P2093
N F Da Silva
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601447
P407
P577
2004-01-01T00:00:00Z